Andrew initially trained as a pharmacist at the University of Otago and worked in New Zealand and the United Kingdom before commencing medical studies at the University of Auckland. He completed ophthalmology specialist training in Dunedin and Christchurch.
Andrew undertook subspecialist fellowship training in glaucoma with Professor Anthony Molteno and vitreoretinal surgery with Professor Philip Polkinghorne in Auckland and subsequently at Bristol Eye Hospital in the UK.
On returning to NZ in 2009, Andrew established a new, state-of-the-art vitreoretinal surgical unit at Dunedin Hospital. He has relocated to Tauranga where he works as a consultant ophthalmologist at Park Street Eye Clinic.
Andrew has authored several publications and coauthored a book chapter on Molteno implants. He has teaching responsibilities for both under- and postgraduate students. Andrew is a College examiner for the Ocular Pharmacology and Emergency Medicine module of the Basic Sciences examination registrars must take on entering the ophthalmology training programme.
Andrew is a trustee of Macular Degeneration New Zealand and belongs to the American Society of Retinal Specialists and the Australian and New Zealand Society of Retinal Specialists. He specialises in cataract, glaucoma and retinal disease.
| The Macular Generation - Saving Sight for your Seniors
Concurrent Workshop Repeated |
|||
| Sunday, 17 August 2014 | Start 8:30am | Duration: 55mins | Room 4 |
| Start 9:35am | Duration: 55mins | Room 4 | |
| MD is the leading cause of blindness in New Zealand. One in 7 New Zealanders over the age of 50 years is affected in some way, and 1 in 4 over the age of 80 years will be blind from MD. The number of people affected is estimated to increase by 70% by 2030 in the absence of effective treatment and prevention measures.
People with MD are more likely to suffer injury from falls and tend to need residential care at higher rates than those with normal sight. There is over 40% higher incidence of depression in MD patients than elderly people without MD. Macular Degeneration (MD) is a progressive disease of the central retina that leads to a loss of central vision and affects the ability to read, drive, recognise faces and anything else that requires fine detailed vision. Whilst there is no cure, risk factors can be modified and prompt treatment saves sight. This workshop will give you an overall understanding of MD and its management. You will learn how to recognise MD in your patients and test their vision appropriately using simple tests, what to recommend to them to positively impact their vision and lives and where to go for further resources. |
|||